Actinium Pharmaceuticals Obtains $3,310,860 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f4ee29f4-7fdf-49b6-8c9b-7183bf0b191a
Date
1/22/2014
Company Name
Actinium Pharmaceuticals
Mailing Address
501 Fifth Avenue 4th Floor New York, NY 10017
Company Description
Actinium Pharmaceuticals, Inc. (API) is a privately held biopharmaceutical company specialized in the development of cancer drugs.
Website
http://www.actiniumpharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$3,310,860
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed